ENRIGHT PATRICK G
SEC CIK 1253886 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | Dir | 21.3K | — | $1.39M | 14 | 2021-07-29 | 2026-08-31 |
| MANE | Veradermics, Inc | Dir, 10% | 2.41M | $18.27M | — | 2 | 2026-02-05 | 2026-02-05 |
| VERA | Vera Therapeutics, Inc. | Dir, 10% | 5,882 | $22.53M | — | 4 | 2022-02-10 | 2025-12-11 |
| ZBIO | Zenas BioPharma, Inc. | Dir | 1.83M | $9.73M | — | 4 | 2024-09-16 | 2025-10-09 |
| BIOA | BioAge Labs, Inc. | Dir | 1.31M | $7.20M | — | 2 | 2024-09-27 | 2024-09-27 |
Most active insiders at JAZZ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | COZADD BRUCE C | Dir | — | $27.15M |
| 2 | Iannone Robert | EVP, CMO, Gbl Head of R, D | — | $20.41M |
| 3 | Patil Neena M | EVP, CLO | — | $11.50M |
| 4 | Carr Patricia | SVP, CAO | — | $2.46M |
| 5 | Winningham Rick E | Dir | — | $1.66M |
| 6 | Pearce Samantha | EVP, Chief Commercial Off | — | $1.63M |
| 7 | Henderson Mary Elizabeth | SVP, Technical Ops | — | $1.42M |
| 8 | McSharry Heather Ann | Dir | — | $1.09M |
| 9 | RIEDEL NORBERT G | Dir | — | $655.7K |
| 10 | GALA RENEE D | Pres, CEO | — | $486.1K |
| 18 | ENRIGHT PATRICK G | Dir | — | — |
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-02 17:17 | 2026-08-31 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | F - Tax | $241.42 | -1,706 | 21.3K | -7% | -$411.9K |
| 2026-08-07 17:37 | 2026-08-05 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | A - Grant | $0.00 | +1,605 | 23.0K | +8% | $0 | |
| DMI | 2026-02-05 | 2026-02-05 | MANE | Veradermics, Inc | ENRIGHT PATRICK G | Dir, 10% | C - Cnv Deriv | — | +3.58M | 2.41M | New | — |
| DMI | 2026-02-05 | 2026-02-05 | MANE | Veradermics, Inc | ENRIGHT PATRICK G | Dir, 10% | P - Purchase | $17.00 | +1.07M | 2.60M | +70% | +$18.27M |
| 2026-01-08 | 2025-08-18 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | J - Other | $0.00 | -5,000 | 21.4K | -19% | $0 | |
| 2025-12-15 | 2025-12-11 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Dir | P - Purchase | $42.50 | +5,882 | 5,882 | New | +$250.0K | |
| I | 2025-10-14 | 2025-10-09 | ZBIO | Zenas BioPharma, Inc. | ENRIGHT PATRICK G | Dir | P - Purchase | $19.00 | +105.3K | 1.83M | +6% | +$2.00M |
| 2025-10-14 | 2025-10-09 | ZBIO | Zenas BioPharma, Inc. | ENRIGHT PATRICK G | Dir | P - Purchase | $20.85 | +12.0K | 12.0K | New | +$250.0K | |
| 2025-08-11 | 2025-08-07 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | A - Grant | $0.00 | +3,507 | 28.2K | +14% | $0 | |
| 2025-08-11 | 2025-08-08 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | F - Tax | $111.25 | -1,805 | 26.4K | -6% | -$200.8K | |
| MI | 2025-06-25 | 2025-06-23+ | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Dir | P - Purchase | $21.11 | +250.0K | 3.57M | +8% | +$5.28M |
| DI | 2024-09-27 | 2024-09-27 | BIOA | BioAge Labs, Inc. | ENRIGHT PATRICK G | Dir | C - Cnv Deriv | — | +1.31M | 1.31M | New | — |
| DI | 2024-09-27 | 2024-09-27 | BIOA | BioAge Labs, Inc. | ENRIGHT PATRICK G | Dir | P - Purchase | $18.00 | +400.0K | 1.71M | +31% | +$7.20M |
| DMI | 2024-09-16 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | ENRIGHT PATRICK G | Dir | C - Cnv Deriv | — | +2.06M | 1.73M | New | — |
| DI | 2024-09-16 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | ENRIGHT PATRICK G | Dir | P - Purchase | $17.00 | +440.0K | 774.5K | +132% | +$7.48M |
| 2024-08-06 | 2024-08-02 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | A - Grant | $0.00 | +3,731 | 24.7K | +18% | $0 | |
| 2023-08-15 | 2023-08-14 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | S - Sale | $138.16 | -1,241 | 20.9K | -6% | -$171.5K | |
| 2023-08-15 | 2023-08-11 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | A - Grant | $0.00 | +3,075 | 22.2K | +16% | $0 | |
| I | 2023-02-08 | 2023-02-06 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Dir, 10% | P - Purchase | $7.00 | +1.71M | 1.71M | New | +$12.00M |
| I | 2022-11-25 | 2022-11-22 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | S - Sale | $152.88 | -2,000 | 0 | -100% | -$305.8K |
| M | 2022-11-25 | 2022-11-22 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | S - Sale | $149.48 | -4,974 | 21.2K | -19% | -$743.5K |
| 2022-08-09 | 2022-08-05 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | A - Grant | $0.00 | +2,561 | 25.2K | +11% | $0 | |
| 2022-08-09 | 2022-08-08 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | S - Sale | $152.33 | -1,089 | 24.1K | -4% | -$165.9K | |
| I | 2022-04-05 | 2022-02-10 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Dir, 10% | P - Purchase | $15.00 | +333.3K | 3.43M | +11% | +$5.00M |
| I | 2021-08-20 | 2021-08-18 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | A - Grant | $137.75 | +2,000 | 2,000 | New | +$275.5K |
| 2021-08-02 | 2021-07-29 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Dir | A - Grant | $0.00 | +2,246 | 22.6K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations